{
    "code": "02025072",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025072",
    "time": "2020-07-31 03:11:05",
    "許可證字號": "衛署藥輸字第025072號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/08\/17",
    "發證日期": "98\/08\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202507203",
    "中文品名": "易安穩膜衣錠 5\/160 毫克",
    "英文品名": "Exforge film-coated tablet 5\/160mg",
    "適應症": "治療高血壓，此複方藥品不適合用於起始治療。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "VALSARTAN, AMLODIPINE BESYLATE",
    "限制項目": "02輸　入",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "FES0106000  NOVARTIS FARMACEUTICA S.A.",
            "製造廠廠址": "RONDA SANTA MARIA, 158, 08210 BARBERA DEL VALLES BARCELONA, SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0088200  NOVARTIS PHARMA. AG",
            "製造廠廠址": "LICHTSTRASSE 35 CH-4056 BASLE SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005100",
            "成分名稱": "VALSARTAN",
            "含量描述": "",
            "含量": "160.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2412402210",
            "成分名稱": "AMLODIPINE BESYLATE",
            "含量描述": "",
            "含量": "6.9400000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "025072_Exforge film-coated tablet 5,160mg-108-06-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025072&Seq=002&Type=10"
        },
        {
            "title": "Exforge160-2-106-03-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025072&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "20915_Exforge_TWI-210420_C-109-05-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025072&Seq=008&Type=9"
        },
        {
            "title": "Exforge 5-160, foil-109-01-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025072&Seq=008&Type=8"
        },
        {
            "title": "Exforge 5-160, FB-109-01-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025072&Seq=007&Type=8"
        },
        {
            "title": "025072_Exforge film-coated tablet 5,160mg-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025072&Seq=006&Type=8"
        },
        {
            "title": "1115262_A17_TW_p1_FB_X-4-108-04-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025072&Seq=005&Type=8"
        }
    ]
}